Risedronate as a therapeutic trial post-hysterectomy in premenopausal women to prevent osteoporosis
المؤلفون المشاركون
Hamid, Ban Hadi
Ali, Ahmad Subayh Abd
Saghir, Halah Abd al-Ghani
المصدر
al-Kindy College Medical Journal
العدد
المجلد 14، العدد 1 (30 يونيو/حزيران 2018)، ص ص. 4-7، 4ص.
الناشر
تاريخ النشر
2018-06-30
دولة النشر
العراق
عدد الصفحات
4
التخصصات الرئيسية
الملخص EN
Background: Osteoporosis is a skeletal defect manifested by a reduction of bone strength as a result of reduced bone mass to the extent that there is a higher risk of fracture even on minor trauma.
Hysterectomy in a premenopausal woman is a well known cause of ovarian failure resulting in an increased risk of osteoporosis.
Objective : To clarify bisphosphonate's preventive effect on osteopenia and osteoporosis in premenopausal women after hysterectomy.
Type of the study: Cross –sectional study.
Method: 84 premenopausal females post hysterectomy aged between 40 – 50 years, were enrolled in this randomized controlled double blinded trail at Al Yarmouk teaching hospital and private clinic in Baghdad for a period of two years from Augest 2011 till July 2013.
Participants were assigned as: 1stgroup (study group 42 women): received risedronate treatment "over a period of one year" with calcium and vitamin D; and 2ndgroup (control group 42 women) were taken as a matched group for:"age, body mass index (BMI) and fracture history", received only calcium and vitamin D as a placebo.
Bone density had been assayed at the end of the year for all participants and evaluated for osteopenia and osteoporosis.
Results: Osteopenia and osteoporosis were significantly lower in the risedronate arm as compared to those not received the drug "14.3% & 11.9% versus 26.1% & 19% respectively".
Conclusion: The bone mineral density results were significantly better in those who received risedronate than those not received the drug.
نمط استشهاد جمعية علماء النفس الأمريكية (APA)
Hamid, Ban Hadi& Ali, Ahmad Subayh Abd& Saghir, Halah Abd al-Ghani. 2018. Risedronate as a therapeutic trial post-hysterectomy in premenopausal women to prevent osteoporosis. al-Kindy College Medical Journal،Vol. 14, no. 1, pp.4-7.
https://search.emarefa.net/detail/BIM-840155
نمط استشهاد الجمعية الأمريكية للغات الحديثة (MLA)
Hamid, Ban Hadi…[et al.]. Risedronate as a therapeutic trial post-hysterectomy in premenopausal women to prevent osteoporosis. al-Kindy College Medical Journal Vol. 14, no. 1 (2018), pp.4-7.
https://search.emarefa.net/detail/BIM-840155
نمط استشهاد الجمعية الطبية الأمريكية (AMA)
Hamid, Ban Hadi& Ali, Ahmad Subayh Abd& Saghir, Halah Abd al-Ghani. Risedronate as a therapeutic trial post-hysterectomy in premenopausal women to prevent osteoporosis. al-Kindy College Medical Journal. 2018. Vol. 14, no. 1, pp.4-7.
https://search.emarefa.net/detail/BIM-840155
نوع البيانات
مقالات
لغة النص
الإنجليزية
الملاحظات
Includes bibliographical references : p. 6-7
رقم السجل
BIM-840155
قاعدة معامل التأثير والاستشهادات المرجعية العربي "ارسيف Arcif"
أضخم قاعدة بيانات عربية للاستشهادات المرجعية للمجلات العلمية المحكمة الصادرة في العالم العربي
تقوم هذه الخدمة بالتحقق من التشابه أو الانتحال في الأبحاث والمقالات العلمية والأطروحات الجامعية والكتب والأبحاث باللغة العربية، وتحديد درجة التشابه أو أصالة الأعمال البحثية وحماية ملكيتها الفكرية. تعرف اكثر